Antimetabolites: all 7,305 studies that test it
Page 47 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary CancerStatus unknownNCT02159820Phase 2/3
- Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring RadiationWithdrawnNCT02159248Phase 1
- Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus RituximabCompletedNCT02157181Phase 2
- Treatment of Keloidscars With Intralesional Triamcinolone and 5-fluorouracil Injections-prospective, Randomized, Controlled Trial - Pilot StudyCompletedNCT02155439Phase 4
- Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic CancerCompletedNCT02154737Phase 1
- Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic LeukemiaActive, not recruitingNCT02153580Phase 1
- A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary CancerActive, not recruitingNCT02151084Phase 2
- Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea TreatmentCompletedNCT02149537Phase 4
- Combination of Chemotherapy and Gefitinib as First-line TreatmentCompletedNCT02148380Not applicable
- Gemcitabine and S-1 for Advanced Biliary Tract CancerCompletedNCT02146703Phase 2
- Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)TerminatedNCT02141477Phase 1
- Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood LymphomaWithdrawnNCT02141100Phase 1/2
- Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic CancerCompletedNCT02138383Phase 1
- Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal CancerStatus unknownNCT02137356Phase 1
- Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic CancerStatus unknownNCT02135822Phase 2
- Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNAActive, not recruitingNCT02135042Phase 2/3
- The Study of Laparoscopic-assisted Percutaneous Catheter-directed Drainage to Treat Early Severe Acute PancreatitisStatus unknownNCT02133014Not applicable
- S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic CancerCompletedNCT02131493Phase 2
- Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02129582Phase 1
- Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid MalignanciesCompletedNCT02129101Phase 1
- Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis AgentsCompletedNCT02128308Phase 1
- Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric CancerCompletedNCT02128243Phase 2
- Safety and Preliminary Efficacy Study of V404 PDS in UveitisTerminatedNCT02125266Phase 1/2
- Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)TerminatedNCT02124369Phase 2
- Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe AsthmaStatus unknownNCT02124226Phase 3
- Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDSStatus unknownNCT02124174Phase 2
- XILO-FIST, the Effect of Allopurinol on the Brain Heart and Blood Pressure After StrokeCompletedNCT02122718Phase 4
- Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesCompletedNCT02122081Phase 1
- Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRMSuspendedNCT02121405Phase 3
- Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic SyndromeCompletedNCT02117219Phase 1
- Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast CancerStatus unknownNCT02115152Phase 2
- Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in MyelomaWithdrawnNCT02114502Phase 2
- Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric CancerCompletedNCT02114359Phase 3
- Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AMLTerminatedNCT02109627Phase 1
- Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological MalignanciesCompletedNCT02106650Phase 2
- Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung AdenocarcinomaStatus unknownNCT02103257Phase 4
- Medication Enhanced Rapid TherapyTerminatedNCT02099825Phase 1
- A Clinical Trial on Efficacy and Safety for Lobaplatin and Gemcitabine in Combination With Docetaxel in the Second-line Treatments on Advanced OsteosarcomaStatus unknownNCT02099396Phase 2/3
- Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable PatientsStatus unknownNCT02099188Phase 2
- Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable PatientsStatus unknownNCT02099175Phase 2
- Bioavailability in Patient With Psoriasis: Metoject Prefilled PenCompletedNCT02097173Phase 1
- Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT02093403Phase 1
- Risk-based Therapy for Sickle Cell Anemia: A Feasibility StudyWithdrawnNCT02090296Phase 2
- Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCCCompletedNCT02089633Phase 2
- Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to OxaliplatinStatus unknownNCT02087475Phase 3
- PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASESCompletedNCT02086656Phase 2
- Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal CancerWithdrawnNCT02085005Phase 2
- Study of Molecular and Genetic Abnormalities in Patients With Myeloid NeoplasmsCompletedNCT02084563Phase 2
- Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell TransplantCompletedNCT02083250Phase 1
- Inflammation Control For Elders: ICE StudyWithdrawnNCT02079948Phase 2
- A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal CancerWithdrawnNCT02079220Phase 2
- Combination Therapy of F8IL10 and Methotrexate in Rheumatoid Arthritis PatientsCompletedNCT02076659Phase 1
- The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）Status unknownNCT02076477Phase 3
- Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AMLCompletedNCT02076191Phase 1/2
- RCT of Methotrexate Added to Treatment As Usual in SchizophreniaCompletedNCT02074319Phase 1
- Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder CancerStatus unknownNCT02074189Phase 3
- Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AMLCompletedNCT02073838Phase 2
- Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid LeukemiaStatus unknownNCT02072811Phase 3
- Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid TumorsCompletedNCT02071537Phase 1
- Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal CancerStatus unknownNCT02071069Phase 2
- Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT02070458Phase 1
- Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal CancerStatus unknownNCT02068131Phase 2
- Hematopoietic Stem Cell Transplant for Sickle Cell DiseaseCompletedNCT02065596Phase 1
- CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantActive, not recruitingNCT02061800Phase 1/2
- Xeloda Maintenance Versus BSC in Metastatic Colorectal CancerTerminatedNCT02060669Phase 3
- Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic CancerCompletedNCT02050178Phase 1
- MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT02049801Phase 1
- Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic CancerWithdrawnNCT02048943Phase 1
- Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCCCompletedNCT02047201Phase 2
- A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALLCompletedNCT02046694Early Phase 1
- Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal CancerWithdrawnNCT02046538Phase 2
- Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02046421Phase 1
- PP-Gemcitabine & External Beam Radiation-SarcomasCompletedNCT02046304Phase 1
- Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid TumorsCompletedNCT02045602Phase 1
- A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic CancerCompletedNCT02045589Phase 1
- Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological MarkerStatus unknownNCT02043821Not applicable
- Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.CompletedNCT02043730Phase 2
- Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic LymphomaTerminatedNCT02043587Phase 2
- Novel Dose Escalation to Predict Treatment With HydroxyureaCompletedNCT02042222Early Phase 1
- MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal CancerCompletedNCT02041481Phase 1
- Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC PatientsStatus unknownNCT02039518Phase 2
- Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)TerminatedNCT02038816Phase 2
- The Maintenance Therapy of Capecitabine of Advanced Gastric CancerStatus unknownNCT02038621Phase 2
- Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.CompletedNCT02035072Phase 2
- Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung CancerStatus unknownNCT02031601Phase 4
- Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT02029950Phase 1
- Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast CancerStatus unknownNCT02028494Not applicable
- Maintenance Treatment With Capecitabine in Colorectal Cancer PatientsStatus unknownNCT02027363Phase 2
- A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid TumorsCompletedNCT02025803Phase 1
- A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast CancerCompletedNCT02025192Phase 1
- Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous CancerStatus unknownNCT02025036Phase 3
- Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic CancerStatus unknownNCT02024633Phase 1
- Efficacy Study of Leflunomide to Treat Juvenile Idiopathic ArthritisStatus unknownNCT02024334Phase 4
- AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine ChemotherapyStatus unknownNCT02024308Phase 4
- Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2CompletedNCT02024009Phase 1/2
- Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative ResectionCompletedNCT02023021Phase 2
- Clinical Guidelines for APL TreatmentStatus unknownNCT02020161Phase 4
- Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDSCompletedNCT02018926Phase 1/2
- Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.CompletedNCT02017457Phase 2
- Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and NeckTerminatedNCT02015650Phase 4